Published by Josh White on 20th April 2022
(Sharecast News) - Oxford Biomedica reported a 63% improvement in total revenues in its preliminary results on Wednesday, to £142.8m, although its outlook was somewhat less rosy amid a pause in vaccine manufacturing.
URL: http://www.digitallook.com/dl/news/story/32615798/...